|
RNF40 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.71710999999908E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.67838999999281E-05 |
| Normal-vs-Stage2 |
9.491200E-01 |
| Normal-vs-Stage3 |
1.49619999945116E-07 |
| Normal-vs-Stage4 |
1.72081999999518E-05 |
| Stage1-vs-Stage2 |
9.68300000000477E-05 |
| Stage1-vs-Stage3 |
5.298300E-02 |
| Stage1-vs-Stage4 |
3.153000E-01 |
| Stage2-vs-Stage3 |
3.50660000003611E-06 |
| Stage2-vs-Stage4 |
2.803100E-04 |
| Stage3-vs-Stage4 |
6.608400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.73970999999273E-05 |
| Normal-vs-AfricanAmerican |
7.176200E-02 |
| Normal-vs-Asian |
1.394670E-04 |
| Caucasian-vs-AfricanAmerican |
2.245600E-01 |
| Caucasian-vs-Asian |
6.804600E-01 |
| AfricanAmerican-vs-Asian |
3.384400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.031150E-04 |
| Normal-vs-Female |
1.99158999999449E-05 |
| Male-vs-Female |
8.971600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.32110000000885E-06 |
| Normal-vs-Age(41-60Yrs) |
1.157250E-04 |
| Normal-vs-Age(61-80Yrs) |
3.563300E-04 |
| Normal-vs-Age(81-100Yrs) |
1.562000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.313800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.897000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.424400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.928600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.588000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.439400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.55624000000021E-05 |
| Classical-VS-Follicular |
1.035170E-01 |
| Classical-VS-Other |
4.892600E-01 |
| Classical-VS-Normal |
2.22429999999774E-05 |
| Tall-VS-Follicular |
1.43360000004478E-06 |
| Tall-VS-Other |
2.040000E-01 |
| Tall-VS-Normal |
3.81850107089576E-11 |
| Follicular-VS-Other |
2.795800E-01 |
| Follicular-VS-Normal |
2.470100E-02 |
| Other-VS-Normal |
1.287590E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.322780E-03 |
| Normal-vs-N1 |
3.59509999547925E-08 |
| N0-vs-N1 |
1.683970E-03 |
|
|
